Source: Eur Respir J 2010; 35: 958-959
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Provencher S., Souza R.. Predicting survival in pulmonary arterial hypertension: time to move forward. Eur Respir J 2010; 35: 958-959

Member's Comments

No comment yet.

Related content which might interest you: Improving survival in pulmonary arterial hypertension Source: Eur Respir J 2005; 25: 218-220 Year: 2005 A critical analysis of survival in pulmonary arterial hypertension Source: Eur Respir Rev 2012 21:218-222 Year: 2012 Impact of initial treatment strategy on long-term survival in pulmonary arterial hypertension (PAH) Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension Year: 2018 Predicting survival in pulmonary arterial hypertension in the UK}, Source: Eur Respir J 2012; 40: 604-611 Year: 2012 Impact on survival of pulmonary function abnormalities in pulmonary arterial hypertension Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009 Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease Source: Eur Respir Rev 2011; 20: 236-242 Year: 2011 Survival in pulmonary arterial hypertension (PAH): impact of 3 different periods of management Source: Annual Congress 2007 - Clinical aspects of pulmonary arterial hypertension Year: 2007 Looking backwards: is it time to assess veno-atrial interactions in pulmonary arterial hypertension? Source: Eur Respir J, 54 (4) 1901598; 10.1183/13993003.01598-2019 Year: 2019 End points for pulmonary arterial hypertension: a way backward Source: Eur Respir J 2004; 24 : 890-891 Year: 2004 Mobile spiroergometry for prediction of survival in pulmonary arterial hypertension (PAH) Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 ‘Idiopathic‘ pulmonary arterial hypertension with preserved lung function but co-existing parenchymal abnormalities: Response to treatment and survival Source: Annual Congress 2012 - Pulmonary circulation: clinical databases and registries Year: 2012 Pulmonary arterial hypertension or left heart disease with pulmonary hypertension? Toward noninvasive clarity, but time for a new paradigm Source: Eur Respir J 2015; 46: 299-302 Year: 2015 The influence of fractional pulse pressure on the outcome of pulmonary thromboendarterectomy Source: Eur Respir J 2001; 17: 653-659 Year: 2001 Validation of two predictive models for survival in pulmonary arterial hypertension Source: Eur Respir J 2015; 46: 152-164 Year: 2015 Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2) Source: Eur Respir J 2015; 45: 1303-1313 Year: 2015 Gas transfer relates to pulmonary haemodynamics and survival in pulmonary arterial hypertension associated with systemic sclerosis Source: Eur Respir J 2007; 30: Suppl. 51, 344s Year: 2007 Hospitalization in patients with pulmonary arterial hypertension: causes and outcomes Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Patterns of mean pulmonary artery pressure (mPAP)-flow relation changes following chronic therapy in idiopathic pulmonary arterial hypertension (IPAH) Source: Eur Respir J 2006; 28: Suppl. 50, 427s Year: 2006 Lower than expected pulsatile pulmonary arterial load in a thromboembolic pulmonary hypertension model Source: International Congress 2018 – Experimental research in pulmonary hypertension Year: 2018 Pulmonary vascular gradient: A predictor of prognosis in pulmonary hypertension due to left heart disease Source: Annual Congress 2012 - Pulmonary circulation: end-points and biomarkers Year: 2012